(PharmaNewsWire.Com, May 26, 2020 ) According to a new market research report "Aseptic Sampling Market by Type (Manual (Type (Traditional, Single use), Product (Bags, Bottles, Syringes, Accessories)), Automatic), Application (Upstream, Downstream), Technique (Off-line, On-line), End User (R&D, CMO) - Global Forecast to 2023", published by MarketsandMarkets™, the market is expected to grow at a CAGR of 13.5% from 2018 to 2023, to reach USD 1,247.0 million in 2023 from USD 662.1 million in 2018.
Based on application, the upstream processes segment is accounted for the largest share of the market in 2018
On the basis of application, the Aseptic Sampling Market is segmented into upstream process and downstream process. In 2018, the upstream process segment is expected to account for the largest share of the market. Being the start of bioproduction, upstream processes form a key application area for aseptic sampling. Any contamination originating from the upstream process will be carried to the following processes and affect overall production, leading to failure. Their importance in this stage is the key factor supporting the use of aseptic sampling products.
Based on type, the manual aseptic sampling segment is expected to account for the largest share of the market in 2018
On the basis of type, the Aseptic Sampling Market is categorized into manual aseptic sampling and automated aseptic sampling. In 2018, the manual aseptic sampling segment is expected to account for the largest share of the Aseptic Sampling Market. Manual Aseptic sampling is again divided into two segments traditional sampling type and single-use sampling type. In 2018, single-use sampling type is expected to account for the largest share in the manual Aseptic Sampling Market. Single-use aseptic sampling systems help drug manufacturers to mitigate cross-contamination and cost issues, leads to a high share in the market.
Europe is expected to dominate the market in 2018
The Europe is expected to account for the largest share of the Aseptic Sampling Market in 2018. Government support for new biologics has encouraged the research and development of biologics. North America is accounted for the second-largest share of the market.
The major players operating in the market include Sartorius Stedim Biotech (France), Merck Millipore (Germany), Danaher (US), and Thermo Fisher Scientific (US).
We are pleased to offer you this exciting, new, and entirely free professional resource. Visit our Free Biotechnology & Pharmaceuticals resource center today to browse our selection of 600+ complimentary Biotechnology & Pharmaceuticals magazines, white papers, webinars, podcasts, and more. Get popular titles including:
